Overview
Koji Haratani is an Oncologist in Boston, Massachusetts. Dr. Haratani is highly rated in 4 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Cancer, and Febrile Neutropenia.
His clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist in Boston, Massachusetts. Dr. Davids is highly rated in 21 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Tissue Biopsy, and Bone Marrow Transplant.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist in Boston, Massachusetts. Dr. Jacobsen is highly rated in 44 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute
Daniel Deangelo is an Oncologist in Boston, Massachusetts. Dr. Deangelo is highly rated in 36 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Koji Haratani
How do I make an appointment with Dr. Koji Haratani?
You can book an appointment with Dr. Koji Haratani by calling their office at 617-632-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Koji Haratani a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Koji Haratani is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Koji Haratani specialize in?
While Dr. Koji Haratani is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Koji Haratani participate in research or clinical trials?
Yes. Dr. Koji Haratani has published 67 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Koji Haratani's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerDr. Haratani isDistinguished. Learn about EGFR Positive Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Haratani isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Febrile NeutropeniaDr. Haratani isAdvanced. Learn about Febrile Neutropenia.
- Lung CancerDr. Haratani isAdvanced. Learn about Lung Cancer.
- Experienced
- Lung AdenocarcinomaDr. Haratani isExperienced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Haratani isExperienced. Learn about Small Cell Lung Cancer (SCLC).